rawfin.tv
AbbVie Shares Decline After 2026 Guidance Cut on Apogee Acquisition
EarningsstocksAI Generated

AbbVie Shares Decline After 2026 Guidance Cut on Apogee Acquisition

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

AbbVie Inc. shares fell following the company's decision to lower its 2026 financial guidance. The revision reflects the impact of its recent acquisition of Apogee Therapeutics.

AbbViePharmaceuticalsEarnings GuidanceM&ABiotech

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks